Nuwellis (NUWE) Share-based Compensation Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.18% |
| Dec 31, 2025 | -40.17% |
| Sep 30, 2025 | -43.37% |
| Jun 30, 2025 | -45.30% |
| Mar 31, 2025 | -29.33% |
| Dec 31, 2024 | -23.58% |
| Sep 30, 2024 | -24.51% |
| Jun 30, 2024 | -19.44% |
| Mar 31, 2024 | -15.28% |
| Dec 31, 2023 | -21.98% |
| Sep 30, 2023 | -20.94% |
| Jun 30, 2023 | -20.13% |
| Mar 31, 2023 | -18.39% |
| Dec 31, 2022 | 8.85% |
| Sep 30, 2022 | 14.66% |
| Jun 30, 2022 | 15.07% |
| Mar 31, 2022 | 7.74% |
| Dec 31, 2021 | 20.00% |
| Sep 30, 2021 | -2.19% |
| Jun 30, 2021 | 5.83% |
| Mar 31, 2021 | 7.52% |
| Dec 31, 2020 | -1.81% |
| Sep 30, 2020 | -16.65% |
| Jun 30, 2020 | -9.86% |
| Mar 31, 2020 | -12.55% |
| Dec 31, 2019 | -11.95% |
| Sep 30, 2019 | 79.68% |
| Jun 30, 2019 | 4.81% |
| Mar 31, 2019 | -10.55% |
| Dec 31, 2018 | -13.66% |
| Sep 30, 2018 | 5.91% |
| Jun 30, 2018 | 28.35% |
| Mar 31, 2018 | 6.38% |
| Dec 31, 2017 | -20.54% |
| Sep 30, 2017 | -10.38% |
| Jun 30, 2017 | 1.80% |
| Mar 31, 2017 | -12.19% |
| Dec 31, 2016 | -19.60% |
| Sep 30, 2016 | -11.03% |
| Jun 30, 2016 | 65.67% |
| Mar 31, 2016 | 67.03% |